2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 26084989 | Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose. | 2015 Aug | 1 |
| 2 | 24879333 | Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: phase 1 dose-escalation study. | 2014 Dec | 1 |